Logos Global Management as of Dec. 31, 2024
Portfolio Holdings for Logos Global Management
Logos Global Management holds 47 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ideaya Biosciences (IDYA) | 9.0 | $77M | 3.0M | 25.70 | |
| Janux Therapeutics (JANX) | 7.8 | $67M | 1.3M | 53.54 | |
| Revolution Medicines (RVMD) | 7.4 | $63M | 1.5M | 43.74 | |
| Cytokinetics Com New (CYTK) | 5.0 | $42M | 900k | 47.04 | |
| Vera Therapeutics Cl A (VERA) | 4.3 | $37M | 875k | 42.29 | |
| Biontech Se Sponsored Ads (BNTX) | 4.0 | $34M | 300k | 113.95 | |
| Merus N V (MRUS) | 3.7 | $32M | 750k | 42.05 | |
| Erasca (ERAS) | 3.7 | $31M | 13M | 2.51 | |
| Insmed Com Par $.01 (INSM) | 3.6 | $31M | 450k | 69.04 | |
| Ocular Therapeutix (OCUL) | 3.5 | $30M | 3.5M | 8.54 | |
| Neurocrine Biosciences (NBIX) | 3.2 | $27M | 200k | 136.50 | |
| Design Therapeutics (DSGN) | 3.0 | $26M | 4.2M | 6.17 | |
| Vaxcyte (PCVX) | 2.9 | $25M | 300k | 81.86 | |
| Akero Therapeutics (AKRO) | 2.6 | $22M | 800k | 27.82 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.5 | $22M | 175k | 123.15 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.2 | $19M | 700k | 27.12 | |
| Olema Pharmaceuticals (OLMA) | 2.2 | $19M | 3.2M | 5.83 | |
| Blueprint Medicines (BPMC) | 2.0 | $17M | 200k | 87.22 | |
| Travere Therapeutics (TVTX) | 2.0 | $17M | 1.0M | 17.42 | |
| Apellis Pharmaceuticals (APLS) | 1.9 | $16M | 500k | 31.91 | |
| Soleno Therapeutics (SLNO) | 1.8 | $16M | 350k | 44.95 | |
| Alkermes SHS (ALKS) | 1.7 | $14M | 500k | 28.76 | |
| Apogee Therapeutics (APGE) | 1.6 | $14M | 300k | 45.30 | |
| Arvinas Ord (ARVN) | 1.6 | $13M | 700k | 19.17 | |
| Annexon (ANNX) | 1.5 | $13M | 2.6M | 5.13 | |
| Disc Medicine (IRON) | 1.5 | $13M | 200k | 63.40 | |
| Spyre Therapeutics Com New (SYRE) | 1.4 | $12M | 500k | 23.28 | |
| Edgewise Therapeutics (EWTX) | 1.2 | $11M | 400k | 26.70 | |
| Dyne Therapeutics (DYN) | 1.2 | $11M | 450k | 23.56 | |
| Pliant Therapeutics (PLRX) | 1.2 | $9.9M | 750k | 13.17 | |
| Bright Minds Biosciences Com New (DRUG) | 1.0 | $8.8M | 245k | 36.02 | |
| Y Mabs Therapeutics | 0.9 | $7.8M | 1.0M | 7.83 | |
| Immunovant (IMVT) | 0.9 | $7.4M | 300k | 24.77 | |
| Geron Corporation (GERN) | 0.8 | $7.1M | 2.0M | 3.54 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $5.5M | 2.2M | 2.48 | |
| Trevi Therapeutics (TRVI) | 0.6 | $5.2M | 1.3M | 4.12 | |
| Astria Therapeutics (ATXS) | 0.5 | $4.5M | 500k | 8.94 | |
| Unicycive Therapeutics | 0.5 | $4.0M | 5.1M | 0.79 | |
| Aerovate Therapeutics (AVTE) | 0.4 | $3.7M | 1.4M | 2.65 | |
| Rapport Therapeutics (RAPP) | 0.4 | $3.7M | 209k | 17.74 | |
| Atyr Pharma Com New (ATYR) | 0.4 | $3.6M | 1.0M | 3.62 | |
| Allakos | 0.4 | $3.5M | 2.9M | 1.21 | |
| Enliven Therapeutics (ELVN) | 0.4 | $3.2M | 140k | 22.50 | |
| Septerna (SEPN) | 0.4 | $3.1M | 134k | 22.90 | |
| Artiva Biotherapeutics (ARTV) | 0.2 | $1.5M | 145k | 10.08 | |
| Glycomimetics | 0.2 | $1.3M | 5.4M | 0.25 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $15k | 67k | 0.23 |
